Discontinuation report BONEFOS
| Report ID | 28705 |
| Drug Identification Number | 01984845 |
| Brand name | BONEFOS |
| Common or Proper name | clodronate disodium |
| Company Name | BAYER INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CLODRONATE DISODIUM |
| Strength(s) | 400MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 120 |
| ATC code | M05BA |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2018-03-31 |
| Actual discontinuation date | 2018-03-27 |
| Remaining supply date | 2018-03-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
| Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.